How much is Vector Biomed worth in 2026?

Vector Biomed has a current valuation of N/A based on their Early Stage VC (Series A) round and secondary market data.

How much funding has Vector Biomed raised?

Vector Biomed has raised N/A in total funding across 1 funding rounds.

Vector Biomed

Other Pharmaceuticals and Biotechnology

Vector Biomed valuation and funding history | Last updated: January 31, 2023 | 1 funding rounds

Current Valuation

N/A

As of January 31, 2023

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series A)

$15.0M

Last Funding

Jan 2023

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
January 31, 2023	Early Stage VC (Series A)	$15.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Vector Biomed is currently valued at N/A as of January 31, 2023.

Track Vector Biomed Valuation Updates

Get notified when Vector Biomed raises new funding or valuation changes

Explore More Data

Detailed analysis for Vector Biomed

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Vector Biomed's valuation history, funding rounds, and growth metrics.

No credit card required

What is Vector Biomed Worth in 2026?

Vector Biomed is a leading private company in the Other Pharmaceuticals and Biotechnology sector. Track Vector Biomed's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Vector Biomed Valuation is Determined

Private company valuations like Vector Biomed's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.